Immune

Developing, funding and conducting clinical trials in immune tolerance

·
Home

Preserving beta cell function with siplizumab in new onset type 1 diabetes

 

DESIGNATE is active, but not currently enrolling participants

  • Home
  • About Type 1 Diabetes
  • About DESIGNATE
  • Am I Eligible?
  • Study Locations

Am I Eligible?

You may be eligible to participate in the DESIGNATE Study if you:

  • Are between the ages of 8 and 45
  • Have been diagnosed with type 1 diabetes within the last 18 months
  • Are in good general health

DESIGNATE is active, but not currently enrolling participants.

Determine if you or your child may be eligible to participate.

Find a DESIGNATE location near you.

  • About ITN
  • More ITN Trials
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials

DESIGNATE is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded).

NIH
  • Home
  • About Type 1 Diabetes
  • About DESIGNATE
  • Am I Eligible?
  • Study Locations
  • About ITN
  • More ITN Trials
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials